Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Application The global orthopedic surgical robots market size was $1200.62 million in 2021 and is predicted to reach $6552.29 million by 2030, representing a CAGR of 20.75% throughout the period of 2021-2030. Orthopedic surgery is primarily for the conditions that are involved with the musculoskeletal system. The demand for this surgery is rising exponentially due to the continuous increase in spinal deformities, joint fractures, musculoskeletal traumas, bone infections, etc. Surgical robots are the most effective and efficient tools that are implemented to aggrandize this orthopedic surgical process. The current implementation of the surgical robots is entirely focused on acetabulum positioning, anterior cruciate ligament reconstruction, arthroscopy, femur preparation, and femoral osteotomies. Moreover, the orthopedic surgical robots market is estimated to witness substantial growth in its robot-assisted orthopedic surgery, CORI knee replacement, and Mako orthopedic robot. COVID-19 Impact The outbreak of the SARS COVID-19 pandemic had an immense impact on all aspects of orthopedic care and practices, including outpatient clinics, resident training, usage of personal training equipment, etc. So, to safeguard healthcare workers and patients, medical services have been widely restricted. Integrating Artificial Intelligence and Machine Learning technologies into surgical robots is a powerful tool to combat the omnipresent fear of pathogen/virus contamination. The legacy of digitization and machine intelligence will surely outlast the pandemic and revolutionize surgical performance and management. Market Dynamics: The orthopedic surgical robots market report explicates the macroeconomic factors that influence the dynamics of the market and its futuristic potential. Market Drivers: The cases of orthopedic alignments such as ligament rupture, hip and knee fracture, osteoarthritis, meniscus tear, expectations for digitization, etc., are continuously increasing. Along with this, the shifting pattern towards implementing surgical robots to perform orthopedical treatments is immensely boosting the market's growth rate. Apart from this, the highly modernized and advanced technologies and a continuous rise of awareness among people regarding obtrusive orthopedic methods are extensively simulating the overall market growth rate. Restraints: Robotic surgeries are much more extortionate than regular surgeries. The price of the robotic equipment required to perform orthopedic surgery adequately is immensely high, ranging between USD 3,200 to USD 6,100. Moreover, the maintenance cost of the surgical robots is also steep, which significantly adds to the extravagant price of robotic surgery. Opportunities: Robotic-Assisted Surgery (R.A.S.) is estimated to be the most trending technology in the future. This highly upgraded and modernized technology comprises a colossal potential in standardizing surgical procedures and enabling Minimal Invasive Surgery (M.I.S.), a technique thereby ushering in a new era of growth. Global Orthopedic Surgical Robots Market Segmentation Analysis: The Orthopedic Surgical Robot Market is broadly segmented based on End-User, and Regions. Based on End-User: Ambulatory Surgical Centers Hospitals Specialty Clinics Others Region Analysis North America US Canada Mexico Rest of North America Europe Germany France U.K Netherlands Switzerland Finland Belgium Russia Italy Spain Turkey Rest of Europe Asia Pacific China Japan India South Korea Singapore Malaysia Australia Thailand Indonesia Philippines Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Based on End-User, the 'Hospitals' segment currently dominates the worldwide market as it persists in well-planned referral networks for responding efficiently to population health needs. In the United States, hospitals spend over USD 852.2 billion on services annually, generating more than USD 2.83 trillion of economic activity. On the other hand, A.S.C. (Ambulatory Surgical Centers) is the fastest-growing market and is assured to significantly impact its overall enhancement rate in the future. Based on Regions, North America dominates the orthopedic surgical robots market due to its highly efficient healthcare infrastructure and aged population. As a result, the robotic surgery market in North America accounted for 40% of the overall market in 2020 and will assert dominance over the market throughout the forecast period. The Asia-Pacific region has the highest growth rate from 2020 to 2028. The growth of the orthopedic surgical robot is primarily driven by the continuous rise in the population of aged people in this region. China accounts for 12% of the people aged 65 or above, which has resulted in a daily advancement in the number of surgeries in this particular region. Competitive Landscape The competitive landscape analysis provides adequate details regarding the key competitors prevailing in the market environment. The comparison is performed based on company overview, total revenue generated, market potential, investment in research and development, company financials, market initiatives, global presence, production capacities, company strengths and weaknesses, production sites and facilities, etc. Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 1200.62 Million The revenue forecast in 2030 USD 6552.29 Million Growth rate CAGR of approximately 20.75% The base year for estimation 2021 Historical data 2016 – 2019 Unit USD Billion, CAGR (2021 - 2028) Segmentation Based on End-User, Based on Region. Based on End-User Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others. Based on Region North America, Europe, Asia Pacific, LAMEA. Country Scope U.S, Canada, France, Germany, U.K, China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Accuray Incorporated, Globus Medical, Auris Health Inc., Smith &Nephew, Johnson & Johnson Services Inc., Medtronic, Nordson Corporation, OMNILife science Inc., Stryker, THINK Surgical Inc., Zimmer Biomet, Intuitive Surgical, Wright Medical Group N.V, Medrobotics Corporation, NuVasive Inc. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. The major players that are covered in the Orthopedic Surgical Robots Market report are: Accuray Incorporated Globus Medical Auris Health Inc. Smith &Nephew Johnson & Johnson Services Inc. Medtronic Nordson Corporation OMNILife Science Inc. Stryker THINK Surgical Inc. Zimmer Biomet Intuitive Surgical Wright Medical Group N.V Medrobotics Corporation NuVasive Inc. Recent Developments Since Feb 2021, the leading market players have focused on High Growth, High Priority Areas in Knees, Hips, S.E.T., and CMFT. It incorporates highly innovative products, such as the Persona Primary, ROSAKnee for robotically-assisted surgeries, Partial, Cementless, and Revision Knee Systems, the Avenir Complete Hip System, OrthoIntel Intelligence Platform, and the G7 Acetabular Hip System. Recently, a leading market player launched an Orthopedic Solutions Business to assist providers in delivering Outcome-Focused Care and Succeed in New Value-Based Bundled Service Models. It is a consultative program that is effectively designed to help providers meet the C.J.R.necessities by reducing system costs while addressing patient satisfaction and outcomes. Frequently Asked Question About This Report What are the various types of orthopaedical robots developed by the key market players? The different types of highly modernized and updated robots that the market leaders develop are da Vinci and Ion by Intuitive Surgical, Mako by Stryker, NAVIO by Smith & Nephew, etc. What is the overall study period of this market? The study period of this market ranges from 2021 to 2030. What is the growth rate of the market? The market is growing steadily with a CAGR of 20.75% throughout the estimated period of 2021 to 2030. How big is the orthopedic surgical robots market? The global orthopedic surgical robots market size was $1200.62 Mn in 2021 and is predicted to reach $6552.29 Mn by 2030, with a CAGR of 20.75%. What is the orthopedic surgical robots market growth? The global orthopedic surgical robots market is expected to grow at a compound annual growth rate (CAGR) of 20.75% from 2021 to 2030 to reach USD6552.29 million by 2030. Which region has the maximum growth rate in the market? The Asia-Pacific (APAC) region has the highest growth rate in this market due to the maximum number of aged people, resulting in a consecutive rise in the number of orthopedic surgeries. . Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Orthopedic Surgical Robots Market Post-Covid-19 Figure 06: Impact of Covid-19 on Orthopaedic Surgical Robots Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2021-2030 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2021-2030 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2021-2030(USD Million) 3.1.4 Market Summary Figure 10: North America to Account for Largest Share of Global Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 11: Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Orthopaedic Surgical Robots Market 5.2.1 Global market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global market, by region, 2021-2030 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global market, by Type, 2021-2030 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Global market, By End-User, 2021-2030 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 market PEST analysis 5.8.2 market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 12 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 13 Market Drivers and Their Impact 6.2.2 Restraints Figure 14 Market Restraints and Their Impact 6.2.3 Opportunities Figure 15 Market Opportunities and Their Impact 6.2.4 Challenges Figure 16 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 17 Value Chain Analysis: Market 6.5 Ecosystem Figure 18 Market: Ecosystem Table 3 Market: Ecosystem Figure 19 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 20 Top 15 Companies with Highest No. of Patents in Last 9 Years Figure 21 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Market 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 6 Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 7 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 8: Key Players market share Figure 22: Key players market share of companies 7.2 Manufacturers Manufacturing Sites, Area Served, End-User 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: End-User Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 9: Market, By End-User, 2021–2028 (USD Million) Figure 23: Market, By End-User, 2021–2028 (USD Million) 8.3 Hospitals 8.3.1 Hospitals market, 2021-2030 (USD Million) Figure 24: Hospitals market, 2021-2030 (USD Million) 8.4 Ambulatory Surgical Centers 8.4.1 Ambulatory Surgical Centers, 2021-2030 (USD Million) Figure 25: Ambulatory Surgical Centers, 2021-2030 (USD Million) 8.5 Specialty Clinics 8.5.1 Specialty Clinics market, 2021-2030 (USD Million) Figure 26: Specialty Clinics- market, 2021-2030 (USD Million) 8.6 Others 8.6.1 Others market, 2021-2030 (USD Million) Figure 27: Others market, 2021-2030 (USD Million) Chapter 9. Global Market: Regional Outlook 9.1 North America Figure 28: North America Market, By Revenue Forecast (2020-2028) 19.1.1 North America market, by country, 2021-2030 (USD Million) Table 10: North America Market, by Country, 2020-2028 Figure 29: North America Market 9.1.2 North America market, by End-User, 2021-2030 (USD Million) Table 11: North America market, by End-User, 2021-2030 (USD Million) Figure 30: North America market, by End-User, 2021-2030 (USD Million) 9.1.3 U.S. 10.1.3.1 U.S. market, by End-User, 2021-2030 (USD Million) Figure 31: U.S. market, by End-User, 2021-2030 (USD Million) 9.1.4 Canada 10.1.4.1 Canada market, by End-User, 2021-2030 (USD Million) Figure 32: Canada market, by End-User, 2021-2030 (USD Million) Figure 33: Canada market, by End-User, 2021-2030 (USD Million) Figure 34: Canada market, by End-User, 2021-2030 (USD Million) 9.2 Europe Figure 35: Europe Market, By Revenue Forecast (2020-2028) 9.2.1 Europe market, by country, 2021-2030 (USD Million) Table 12: Europe market, by country, 2021-2030 (USD Million) Figure 36: Europe market, by country, 2021-2030 (USD Million) 9.2.2 Europe market, by End-User, 2021-2030 (USD Million) Table 13: Europe market, by End-User, 2021-2030 (USD Million) Figure 37: Europe market, by End-User, 2021-2030 (USD Million) 9.2.3 U.K. 9.2.3.1 U.K. market, by End-User, 2021-2030 (USD Million) Figure 38: U.K. market, by End-User, 2021-2030 (USD Million) 9.2.4 Germany 9.2.4.1 Germany market, by End-User, 2021-2030 (USD Million) Figure 39: Germany market, by End-User, 2021-2030 (USD Million) 9.2.5 France 9.2.5.1 France market, by End-User, 2021-2030 (USD Million) Figure 40: France market, by End-User, 2021-2030 (USD Million) 9.2.6 Rest of Europe 9.2.6.1 Rest of Europe market, by End-User, 2021-2030 (USD Million) Figure 41: Rest of Europe market, by End-User, 2021-2030 (USD Million) 9.3 Asia Pacific Figure 42: Asia Pacific Market, By Revenue Forecast (2020-2028) 9.3.1 Asia Pacific market, by country, 2021-2030 (USD Million) Table 14: Asia Pacific market, by country, 2021-2030 (USD Million) Figure 43: Asia Pacific market, by country, 2021-2030 (USD Million) 9.3.2 Asia Pacific market, by End-User, 2021-2030 (USD Million) Table 15: Asia Pacific market, by End-User, 2021-2030 (USD Million) Figure 44: Asia Pacific market, by End-User, 2021-2030 (USD Million) 9.3.3 China 9.3.3.1 China market, by End-User, 2021-2030 (USD Million) Figure 45: China market, by End-User, 2021-2030 (USD Million) 9.3.4 India 9.3.4.1 India market, by End-User, 2021-2030 (USD Million) Figure 46: India market, by End-User, 2021-2030 (USD Million) 9.3.5 Japan 9.3.5.1 Japan market, by Type, 2021-2030 (USD Million) Figure 47: Japan market, by Type, 2021-2030 (USD Million) 9.3.5.2 Japan market, by End-User, 2021-2030 (USD Million) Figure 48: Japan market, by End-User, 2021-2030 (USD Million) 9.3.6 South Korea 9.3.6.1 South Korea market, by End-User, 2021-2030 (USD Million) Figure 49: South Korea market, by End-User, 2021-2030 (USD Million) 9.3.7 Rest of APAC 9.3.7.1 Rest of APAC market, by End-User, 2021-2030 (USD Million) Figure 50: Rest of APAC market, by End-User, 2021-2030 (USD Million) 9.4 Latin America Figure 51: Latin America Market, By Revenue Forecast (2020-2028) 9.4.1 Latin America market, by country, 2021-2030 (USD Million) Table 16: Latin America market, by country, 2021-2030 (USD Million) Figure 52: Latin America market, by country, 2021-2030 (USD Million) 9.4.2 Latin America market, by End-User, 2021-2030 (USD Million) Table 17: Latin America market, by End-User, 2021-2030 (USD Million) Figure 53: Latin America market, by End-User, 2021-2030 (USD Million) 9.4.3 Brazil 9.4.3.1 Brazil market, by End-User, 2021-2030 (USD Million) Figure 54: Brazil market, by End-User, 2021-2030 (USD Million) 9.4.4 Mexico 9.4.4.1 Mexico market, by End-User, 2021-2030 (USD Million) Figure 55: Mexico market, by End-User, 2021-2030 (USD Million) 9.4.5 Rest of the Latin America 9.4.5.1 Rest of the Latin America market, by End-User, 2021-2030 (USD Million) Figure 56: Rest of the Latin America market, by End-User, 2021-2030 (USD Million) 9.5 MEA Figure 57: MEA Market, By Revenue Forecast (2020-2028) 9.5.1 MEA market, by End-User, 2021-2030 (USD Million) Figure 58: MEA market, by End-User, 2021-2030 (USD Million) Chapter 10. Competitive Landscape 10.1 Accuray Incorporated. 10.1.1 Company overview 10.1.2 Financial performance 10.1.3 Product Portfolio Analysis 10.1.4 Business Strategy & Recent Development 10.2 Globus Medical. 10.2.1 Company overview 10.2.2 Financial performance 10.2.3 Product Portfolio Analysis 10.2.4 Business Strategy & Recent Development 10.3 Auris Health Inc. 10.3.1 Company overview 10.3.2 Financial performance 10.3.3 Product Portfolio Analysis 10.3.4 Business Strategy & Recent Development 10.4 Smith & Nephew. 10.4.1 Company overview 10.4.2 Financial performance 10.4.3 Product Portfolio Analysis 10.4.4 Business Strategy & Recent Development 10.5 Johnson & Johnson Services Inc. 10.5.1 Company overview 10.5.2 Financial performance 10.5.3 Product Portfolio Analysis 10.5.4 Business Strategy & Recent Development 10.6 Medtronic. 10.6.1 Company overview 10.6.2 Financial performance 10.6.3 Product Portfolio Analysis 10.6.4 Business Strategy & Recent Development 10.7 Nordson Corporation. 10.7.1 Company overview 10.7.2 Financial performance 10.7.3 Product Portfolio Analysis 10.7.4 Business Strategy & Recent Development 10.8 OMNILife science Inc. 10.8.1 Company overview 10.8.2 Financial performance 10.8.3 Product Portfolio Analysis 10.8.4 Business Strategy & Recent Development 10.9 Stryker. 10.9.1 Company overview 10.9.2 Financial performance 10.9.3 Product Portfolio Analysis 10.9.4 Business Strategy & Recent Development 10.10 THINK Surgical Inc. 10.10.1 Company overview 10.10.2 Financial performance 10.10.3 Product Portfolio Analysis 10.10.4 Business Strategy & Recent Development 10.11 Zimmer Biomet. 10.11.1 Company overview 10.11.2 Financial performance 10.11.3 Product Portfolio Analysis 10.11.4 Business Strategy & Recent Development 10.12 Intuitive Surgical. 10.12.1 Company overview 10.12.2 Financial performance 10.12.3 Product Portfolio Analysis 10.12.4 Business Strategy & Recent Development 10.13 Wright Medical Group N.V. 10.13.1 Company overview 10.13.2 Financial performance 10.13.3 Product Portfolio Analysis 10.9.4 Business Strategy & Recent Development 10.9 Medrobotics Corporation. 10.9.1 Company overview 10.9.2 Financial performance 10.9.3 Product Portfolio Analysis 10.9.4 Business Strategy & Recent Development 10.9 NuVasive Inc. 10.9.1 Company overview 10.9.2 Financial performance 10.9.3 Product Portfolio Analysis 10.9.4 Business Strategy & Recent Development